Verastem Inc (VSTM):企業の財務・戦略的SWOT分析

◆英語タイトル:Verastem Inc (VSTM) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH289833FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥76,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥115,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Verastem Inc (Verastem) is a biopharmaceutical company which focus on the discovery, development and commercialization of novel small molecule drugs to treat cancer. The company’s marketed product COPIKTRA, an oral inhibitor of phosphoinositide 3-kinase (PI3K) is used to hematologic malignancies. Its pipeline products include VS-6766 a unique inhibitor of the RAF/MEK signaling pathway is used for the treatment of certain types of hematologic and solid cancers, T-cell lymphoma, lung cancer, neck cancer, mesothelioma, ovarian cancer and other advanced cancers. The company operates laboratory in Needham, Massachusetts, the US and has operational presence in Germany. Verastem is headquartered in Needham, Massachusetts, the US.

Verastem Inc Key Recent Developments

Mar 18,2021: Verastem Oncology Reports Fourth Quarter and Full Year 2020 Financial Results, Clinical Updates and Guidance for Key Milestones in 2021 and 1H 2022
Mar 02,2021: Verastem Oncology to Participate in the H.C. Wainwright Global Life Sciences Conference
Jan 20,2021: Frank Neumann, M.D., Ph.D., to Depart Verastem Oncology
Jan 06,2021: Verastem Oncology Appoints Frank Neumann, M.D., Ph.D., as Chief Medical Officer

This comprehensive SWOT profile of Verastem Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Verastem Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Verastem Inc – Key Information
Verastem Inc – Overview
Verastem Inc – Key Employees
Verastem Inc – Key Employee Biographies
Verastem Inc – Key Operational Heads
Verastem Inc – Major Products and Services
Verastem Inc – History
Verastem Inc – Company Statement
Verastem Inc – Locations And Subsidiaries
Verastem Inc
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Verastem Inc – Business Description
Verastem Inc – Corporate Strategy
Verastem Inc – SWOT Analysis
SWOT Analysis – Overview
Verastem Inc – Strengths
Verastem Inc – Weaknesses
Verastem Inc – Opportunities
Verastem Inc – Threats
Verastem Inc – Key Competitors

Section 3 – Company Financial Performance Charts

Verastem Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Verastem Inc, Key Information
Verastem Inc, Key Ratios
Verastem Inc, Share Data
Verastem Inc, Major Products and Services
Verastem Inc, History
Verastem Inc, Key Employees
Verastem Inc, Key Employee Biographies
Verastem Inc, Key Operational Heads
Verastem Inc, Other Locations
Verastem Inc, Subsidiaries
Verastem Inc, Key Competitors
Verastem Inc, SWOT Analysis
Verastem Inc, Ratios based on current share price
Verastem Inc, Annual Ratios
Verastem Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Verastem Inc (VSTM):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Homology Medicines, Inc. (FIXX):製薬・医療:M&Aディール及び事業提携情報
    Summary Homology Medicines, Inc. (Homology Medicines) is a pre-clinical stage biopharmaceutical company engaged in translating gene editing and gene therapy into novel treatment for patients suffering from rare genetic diseases. It offers HMI-102 product, which is in clinical stage for the treatment …
  • Nurix Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Nurix Inc (Nurix) formerly Kura Therapeutics Inc, is a drug development company that discovers and develops drugs which work by modulating the protein regulation machinery of the cell. The company developed a drug discovery platform based on understanding of the ubiquitin proteasome system ( …
  • Bank of Jinzhou Co Ltd :企業の戦略・SWOT・財務情報
    Bank of Jinzhou Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Bank of Jinzhou Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • IMAX Corporation:企業のM&A・事業提携・投資動向
    IMAX Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's IMAX Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), dives …
  • Brookdale Senior Living, Inc.:企業の戦略・SWOT・財務分析
    Brookdale Senior Living, Inc. - Strategy, SWOT and Corporate Finance Report Summary Brookdale Senior Living, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • KDDI Corporation:企業の戦略・SWOT・財務分析
    KDDI Corporation - Strategy, SWOT and Corporate Finance Report Summary KDDI Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Total Brain Ltd (TTB):企業の財務・戦略的SWOT分析
    Summary Total Brain Ltd (TBL) formerly, Brain Resource Ltd is a healthcare service provider that offers therapies. The company carries out research and development of brain products. TBL’s products comprise iSPOT, Total Brain and MyBrainSolutions. The company’s Total Brain is a brain health solution …
  • PTC Inc.:企業のM&A・事業提携・投資動向
    PTC Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's PTC Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital …
  • Genome British Columbia:医療機器:M&Aディール及び事業提携情報
    Summary Genome British Columbia (Genome BC) is a non-profit medical research organization that conducts genomics and proteomics research, and offers science and technology solutions. The organization provides prognostic, new diagnostic, and therapeutic tools for use in personalized medicine. It also …
  • Futuren (FTRN):企業の財務・戦略的SWOT分析
    Futuren (FTRN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • IOL Chemicals and Pharmaceuticals Ltd (IOLCP):企業の財務・戦略的SWOT分析
    IOL Chemicals and Pharmaceuticals Ltd (IOLCP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stre …
  • CHDI Foundation Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary CHDI Foundation Inc (CHDI) is a non-profit biomedical research organization that discovers and develops drugs for Huntington’s disease. The organization’s activities include identification and validation of therapeutic targets, drug discovery and development, and clinical studies and trials. …
  • Voltamp Transformers Ltd (VOLTAMP):企業の財務・戦略的SWOT分析
    Voltamp Transformers Ltd (VOLTAMP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Cape plc:企業の戦略・SWOT・財務情報
    Cape plc - Strategy, SWOT and Corporate Finance Report Summary Cape plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Myelin Repair Foundation:製薬・医療:M&Aディール及び事業提携情報
    Summary Myelin Repair Foundation (MRF) is a medical research organization that discovers and develops myelin repair therapeutics for multiple sclerosis. The organization publishes various peer-reviewed scientific articles, identifies different myelin repair treatment targets and discovers multiple r …
  • SkylineDx BV:企業の製品パイプライン分析
    Summary SkylineDx BV (SkylineDx) is a developer and commercializer of gene signature-based diagnostic tests for personalized medicine in oncology. The company offers MMprofiler and AMLprofiler molecular diagnostic tests for blood cancers. Its AMLprofiler is a vitro diagnostic test that recognizes ac …
  • ACHEM Technology Corporation:企業の戦略・SWOT・財務情報
    ACHEM Technology Corporation - Strategy, SWOT and Corporate Finance Report Summary ACHEM Technology Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Miltenyi Biotec GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary Miltenyi Biotec GmbH (Miltenyi) is a biotechnology company that offers biomedical research and cellular therapy products for cell isolation, flow cytometry, sample preparation and cell culture. The company offers sample preparation, cell separation, flow cytometry, cell culture and stimulati …
  • A-Sonic Aerospace Limited:企業の戦略・SWOT・財務分析
    A-Sonic Aerospace Limited - Strategy, SWOT and Corporate Finance Report Summary A-Sonic Aerospace Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Vycor Medical Inc (VYCO):企業の財務・戦略的SWOT分析
    Summary Vycor Medical Inc (Vycor) is a medical device company that develops, designs, and markets medical devices for use in neurosurgery. The company offers computer-based light stimulation therapies for patients suffering from vision loss resulting from neurological trauma such as stroke. It provi …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆